These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34398053)

  • 21. Insulin-induced lipohypertrophy: report of a case with histopathology.
    Fujikura J; Fujimoto M; Yasue S; Noguchi M; Masuzaki H; Hosoda K; Tachibana T; Sugihara H; Nakao K
    Endocr J; 2005 Oct; 52(5):623-8. PubMed ID: 16284443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.
    Blanco M; Hernández MT; Strauss KW; Amaya M
    Diabetes Metab; 2013 Oct; 39(5):445-53. PubMed ID: 23886784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipohypertrophy.
    Kalra S; Jawad F
    J Pak Med Assoc; 2016 Jun; 66(6):779-80. PubMed ID: 27339591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 25. Frequency of lipodystrophy induced by recombinant human insulin.
    Hajheydari Z; Kashi Z; Akha O; Akbarzadeh S
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1196-201. PubMed ID: 22165682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Diagnostic Value of High-Frequency Ultrasound Technology for Subcutaneous Lipohypertrophy in Diabetes Patients Receiving Insulin Injections.
    Sun ZH; Yu CH; Wang X
    Diabetes Metab Syndr Obes; 2024; 17():1359-1366. PubMed ID: 38525163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-glycemic Adverse Effects of Insulin.
    Guarneri AM; Hoffman RP
    Curr Diabetes Rev; 2022; 18(2):e012821190877. PubMed ID: 33511950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of insulin induced lipohypertrophy on carotid intima-media thickness in patients with type 2 diabetes mellitus.
    Kirac CO; Sirikci V; Findikli HA
    Medicine (Baltimore); 2023 Sep; 102(39):e34696. PubMed ID: 37773793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local complications of insulin administration sites and effect on diabetes management.
    Demir G; Er E; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Nurs; 2022 Sep; 31(17-18):2530-2538. PubMed ID: 34622517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-induced lipodystrophy and interest of insulin injection ports.
    Ben Abdelkrim A; Fathallah N; Omri M; Hasni Y; Khaldi S; Kacem M; Chaieb M; Ben Salem C; Maaroufi A; Ach K
    Therapie; 2019 Dec; 74(6):680-682. PubMed ID: 31088690
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
    Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
    Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1-year prospective observational study with suggestions to minimize clinical impact.
    Rabbone I; Minuto N; Toni S; Lombardo F; Iafusco D; Marigliano M; Schiaffini R; Maltoni G; Frongia AP; Scardapane M; Nicolucci A; Cherubini V; Bonfanti R; Scaramuzza AE;
    Diabetes Obes Metab; 2018 Nov; 20(11):2551-2556. PubMed ID: 29893044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Insulin application techniques in adult patients with diabetes].
    Pelcl T; Prázný M
    Vnitr Lek; 2016; 62(6):486-90. PubMed ID: 27485848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.
    Campinos C; Le Floch JP; Petit C; Penfornis A; Winiszewski P; Bordier L; Lepage M; Fermon C; Louis J; Almain C; Morel D; Hirsch L; Strauss KW
    Diabetes Technol Ther; 2017 Nov; 19(11):623-632. PubMed ID: 29058477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations.
    Spollett G; Edelman SV; Mehner P; Walter C; Penfornis A
    Diabetes Educ; 2016 Aug; 42(4):379-94. PubMed ID: 27216036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes.
    Babar GS; Ali O; Parton EA; Hoffmann RG; Alemzadeh R
    Diabetes Technol Ther; 2009 Mar; 11(3):131-7. PubMed ID: 19216689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial.
    Chen L; Xing Q; Li J; Zhou J; Yuan Y; Wan Y; Pflug BK; Strauss KW; Hirsch LJ
    Diabetes Ther; 2021 Mar; 12(3):813-826. PubMed ID: 33570716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.
    Gentile S; Guarino G; Della Corte T; Marino G; Fusco A; Corigliano G; Colarusso S; Piscopo M; Improta MR; Corigliano M; Martedi E; Oliva D; Russo V; Simonetti R; Satta E; Romano C; Vaia S; Strollo F; ;
    Diabetes Ther; 2021 Jan; 12(1):107-119. PubMed ID: 33219928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
    Guo W; Tian W; Lin L; Xu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.